Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

Medical device stocks

Ready to invest in the health product industry? Consider these 9 stocks.

The best medical device stocks depend on your portfolio and investment goals — while volatility can be ideal for day traders, long-term investors will want to look to stocks with steadier gains over time.

9 medical device stocks to watch

We round up a selection of stocks in or related to the health product industry, weighting the list more heavily towards popular mid- and large-cap US stocks.

  1. Abbott Laboratories (ABT)
  2. ABIOMED (ABMD)
  3. Align Technology (ALGN)
  4. Edwards Lifesciences (EW)
  5. Boston Scientific (BSX)
  6. Medtronic (MDT)
  7. Penumbra (PEN)
  8. Inogen (INGN)
  9. SmileDirectClub (SDC)

Compare trading platforms

Compare online trading platforms by fees, asset types and bonuses to find the best for your investment in medical device stocks.
1 - 6 of 6
Name Product Available asset types Signup bonus
SoFi Invest
Finder Rating: 4.6 / 5: ★★★★★

Finder Award
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
Get up to $1,000 in stock
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
tastytrade
Finder Rating: 4.1 / 5: ★★★★★
tastytrade
Stocks, Options, ETFs, Cryptocurrency, Futures
Get $100 - $2,000
when you you open and fund an account with $5,000 to $100,000+
Highly commended for Best Derivatives Trading Platform award.
eToro
Finder Rating: 4.2 / 5: ★★★★★

Finder Award
EXCLUSIVE
eToro
Stocks, Options, ETFs, Cryptocurrency
FINDER EXCLUSIVE: Get a guaranteed $15 bonus
when you sign up and deposit $100
Winner of Finder’s Best Broker for Beginners award. Not available in NY, NV, MN, TN, and HI.
Public.com
Finder Rating: 4 / 5: ★★★★★
Public.com
Stocks, ETFs, Cryptocurrency, Art, Treasury Bills, Collectibles
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
2.5% fee applies to all alternative asset transactions.
Robinhood
Finder Rating: 4.2 / 5: ★★★★★
Robinhood
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4.9% interest on uninvested cash in your account with Robinhood Gold.
Wealthfront
Finder Rating: 4 / 5: ★★★★★
Wealthfront
Stocks, ETFs
N/A
Wealthfront builds a free financial plan for the life you want and automate your investments at a low cost.
loading

*Signup bonus information updated weekly.

Take a deeper dive into medical device stocks

If you're interested in investing in the health product industry, take a closer look at what companies in this industry do and how the stocks have historically performed. Keep in mind that positive past performance doesn't guarantee that a stock will continue to rise in the future.

1. Abbott Laboratories (ABT)

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon.

Abbott Laboratories stock opened the day at $95.76 after a previous close of $96.85. The latest price was $95.73 (25-minute delay). Abbott Laboratories is listed on the NYSE, has a trailing 12-month revenue of around USD40.2 billion and employs 115,000 staff.

  • Market capitalization: $170,273,521,664
  • P/E ratio: 33.4881
  • PEG ratio: 18.7638

Back to top


2. ABIOMED (ABMD)

Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients.

ABIOMED stock opened the day at $381.02 after a previous close of $381.02. The latest price was $381.02 (25-minute delay). ABIOMED is listed on the NASDAQ, has a trailing 12-month revenue of around USD$1.1 billion and employs 2,003 staff.

  • Market capitalization: $17,180,649,472
  • P/E ratio: 65.3551
  • PEG ratio: 2.75

Back to top


3. Align Technology (ALGN)

Align Technology, Inc. designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, China, and internationally. It operates in two segments, Clear Aligner; and Imaging Systems and CAD/CAM Services (Systems and Services).

Align Technology stock opened the day at $302.97 after a previous close of $305.32. The latest price was $299.76 (25-minute delay). Align Technology is listed on the NASDAQ, has a trailing 12-month revenue of around USD$3.7 billion and employs 22,910 staff.

  • Market capitalization: $23,534,876,672
  • P/E ratio: 75.0024
  • PEG ratio: 10.7985

Back to top


4. Edwards Lifesciences (EW)

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy.

Edwards Lifesciences stock opened the day at $68.86 after a previous close of $69.28. The latest price was $69.18 (25-minute delay). Edwards Lifesciences is listed on the NYSE, has a trailing 12-month revenue of around USD$5.7 billion and employs 17,300 staff.

  • Market capitalization: $42,347,433,984
  • P/E ratio: 31.6636
  • PEG ratio: 3.0653

Back to top


5. Boston Scientific (BSX)

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through MedSurg and Cardiovascular segments. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems.

Boston Scientific stock opened the day at $52.49 after a previous close of $52.80. The latest price was $52.81 (25-minute delay). Boston Scientific is listed on the NYSE, has a trailing 12-month revenue of around USD$13.4 billion and employs 45,000 staff.

  • Market capitalization: $78,145,421,312
  • P/E ratio: 90.4576
  • PEG ratio: 2.5307

Back to top


6. Medtronic (MDT)

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products.

Medtronic stock opened the day at $77.90 after a previous close of $78.36. The latest price was $77.77 (25-minute delay). Medtronic is listed on the NYSE, has a trailing 12-month revenue of around USD$31.6 billion and employs 95,000 staff.

  • Market capitalization: $106,801,643,520
  • P/E ratio: 29.6199
  • PEG ratio: 3.0399

Back to top


7. Penumbra (PEN)

Penumbra, Inc. , together with its subsidiairies, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device, and Penumbra ENGINE brands, as well as components and accessories; neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400, POD400, PAC400, and Penumbra SMART Coil brand names; and neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, BMX96, DDC, SENDit, and PX SLIM brands.

Penumbra stock opened the day at $273.78 after a previous close of $273.20. The latest price was $276.55 (25-minute delay). Penumbra is listed on the NYSE, has a trailing 12-month revenue of around USD$937.8 million and employs 3,900 staff.

  • Market capitalization: $9,440,438,272
  • P/E ratio: 331.9054
  • PEG ratio: -62.27

Back to top


8. Inogen (INGN)

Inogen, Inc. , a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.

Inogen stock opened the day at $66.22 after a previous close of $66.50. The latest price was $66.35 (25-minute delay). Inogen is listed on the NASDAQ, has a trailing 12-month revenue of around USD$349.3 million and employs 1,026 staff.

  • Market capitalization: $121,771,128
  • PEG ratio: 3.48

Back to top


9. SmileDirectClub (SDC)

SmileDirectClub, Inc. , an oral care company, offers clear aligner therapy treatment. The company manages the end-to-end process, which include marketing, aligner manufacturing, fulfillment, treatment by a customer's dentist or orthodontist, and facilitating remote clinical monitoring through a network of orthodontists and general dentists through its proprietary teledentistry platform, SmileCheck in the United States, Puerto Rico, Canada, Australia, the United Kingdom, New Zealand, Ireland, Hong Kong, Germany, Singapore, France, Spain, and Austria.

SmileDirectClub stock opened the day at $7.80 after a previous close of $7.60. The latest price was $7.82 (25-minute delay). SmileDirectClub is listed on the NASDAQ, has a trailing 12-month revenue of around USD$414.9 million and employs 2,700 staff.

  • Market capitalization: $190,872,512

Back to top

How to buy medical device stocks

Sign up with an online broker or platform to invest in one or more of these medical device stocks.

  1. Compare share trading platforms. Use our comparison table to narrow down top brokers by fees and bonuses.
  2. Open and fund your brokerage account. You’ll need personal and financial details, like your contact and bank information.
  3. Search for the stock you're interested in. Find the stock by name or ticker symbol, like ABT or ABMD.
  4. Decide on how many to buy. Some brokers will allow you to purchase fractional shares, while others require you to purchase whole shares.
  5. Choose an order type. Invest in the medical device stocks now with a market order or use a limit order to delay your purchase until the stock reaches your desired price.
  6. Buy the stock. Tap or click the Buy button on your brokerage account. Once you’ve invested in the health product industry, track how your stock performs to decide when it’s time to sell.

Bottom line

While it’s possible to turn a profit investing in medical device stocks, keep in mind that — like any investment — medical device stocks are not immune to risk. These stocks are subject to fluctuating conditions — both in the market and in the health product industry, so carefully vet your picks before you invest. And if you’re new to investing, or if it’s been awhile since you’ve taken a critical look at your investing accounts, compare brokers to make sure you’re getting the best features in your trading account.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

More guides on Finder

Ask an Expert

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site